Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?

To: Sheldon C. who wrote (2726)	1/26/1998 1:51:00 PM
From: Hockeyfan	Read Replies (1) \| Respond to of 4676

Sheldon, I am so busy these days that I usually don't post unless I have facts that need to be aired. I don't have time to slam you guys or anybody else. I don't completely understand HA-API. I am not sure the any of the NRiD thread readers do either. Jaffo is apparently mortgaging his house to buy NRiD based on his expectations that HA-API will generate instant riches. I tried to provide feedback to the thread readers from the competition. Randy's answer to my HA-API quaestion was far from clear. It lead my to believe that he does not know what HA-API is. Contrary to you beliefs, IDX does srite its own APIs. In fact Randy claims that IDX is the market leader for comercially installed biometric APIs. I am not sure if any of them involve layered biometrics. Jaffo and Bob Jordan continue to keep their heads in the sand regarding NRiD competitors. Identix does write APIs, they are not just a hardware company and they will compete directly with NRiD for healthcare Bio-ID applications. I am not trying to rub your noses in it because it remains to be seen who will win in the markets the companies have in common, but to deny that NRiD has any competitors in the healthcare market is plain wrong an a disservice to your thread readers that rely on your wisdom. We can disagree how to interpret the facts but the facts remain the same. J. Saf